TY  - GEN
AU  - Horgan,A M
AU  - Darling,G
AU  - Wong,R
AU  - Guindi,M
AU  - Liu,G
AU  - Jonker,D J
AU  - Lister,J
AU  - Xu,W
AU  - MacKay,H M
AU  - Dinniwell,R
AU  - Kim,J
AU  - Pierre,A
AU  - Shargall,Y
AU  - Asmis,T R
AU  - Agboola,O
AU  - Seely,A J
AU  - Ringash,J
AU  - Wells,J
AU  - Marginean,E C
AU  - Haider,M
AU  - Knox,J J
TI  - Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial
SN  - 1442-2050
PY  - 2017///0425
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Chemoradiotherapy
KW  - Chemotherapy, Adjuvant
KW  - mortality
KW  - Cisplatin
KW  - Esophageal Neoplasms
KW  - Esophagectomy
KW  - Esophagogastric Junction
KW  - pathology
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Postoperative Period
KW  - Pyrroles
KW  - Sunitinib
KW  - Survival Rate
KW  - Withholding Treatment
KW  - statistics & numerical data
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1111/dote.12444
ER  -